Bradford K. Amman, the Chief Financial Officer of Vivos Therapeutics, Inc. (VVOS), has engaged in a transaction involving the company's common stock on June 20, 2024. Following the transaction, Amman directly holds a total of 80 shares of Vivos Therapeutics. The nature of the shares is direct, indicating personal ownership. The transaction details, including the number of shares transacted and the price, have not been disclosed. This financial activity is part of the regular disclosure of stock transactions by company insiders, which can be an indicator of the company's financial health and management's confidence in the business.

Bradford K. Amman, the Chief Financial Officer of Vivos Therapeutics, Inc. (VVOS), has engaged in a transaction involving the company's common stock on June 20, 2024. Following the transaction, Amman directly holds a total of 80 shares of Vivos Therapeutics. The nature of the shares is direct, indicating personal ownership. The transaction details, including the number of shares transacted and the price, have not been disclosed. This financial activity is part of the regular disclosure of stock transactions by company insiders, which can be an indicator of the company's financial health and management's confidence in the business.